Resistance to antimicrobial agents is prevalent among Staphylococci. This has led to wide uses of macrolide-lincosamide-streptogramin B (MLSB) antibiotics to treat Staphylococcus aureus (S. aureus) infections. MLSB though chemically distinct, have similar target site and mode of action. The multiple mechanisms are responsible for resistance to MLSB antibiotics which can lead to clinical failure. The aim of the study was to investigate the frequency of inducible and constitutive clindamycin resistance among clinical isolates of S. aureus and their relationship with Methicillin-resistant Staphylococcus aureus (MRSA).
Introduction
Staphylococcus aureus (S. aureus) is one of the most frequent microorganisms responsible for both community and hospital acquired infections. Methicillin resistance Staphylococcus aureus (MRSA) which are resistance to multiple classes of antibiotics often pose problems in therapy. This has renewed concern for the usage of Macrolide-Lincosamide-Streptogramin B (MLSB) antibiotics to treat S. aureus infections [1] . Clindamycin, a lincosamide, is a preferred option to treat infections, especially skin and soft tissue caused by both methicillin resistant and methicillin susceptible S. aureus because of the various reasons [2] . However, because of extensive use of MLSB antibiotics high incidence MLSB resistant Staphylococcal strains are reported [3, 4] . The resistance to macrolide is either due to active efflux of antibiotics mediated by protein encoded by msrA gene or due to modification of ribosome by r-RNA methylase enzymes encoded by erm genes which confer inducible or constitutive resistance to MLSB antibiotics. In constitutive resistance (cMLSB), the enzyme r-RNA methylase is constitutively produced while in inducible resistance (iMLSB) it is produced only in the presence of inducible agent [5] . Low level erythromycin is the most efficient inducer of iMLSB resistance. In vitro, constitutively resistance Staphylococcus aureus are resistant to both erythromycin and clindamycin whereas those with inducible resistance are resistant to erythromycin and appear sensitive to clindamycin [6] . If clindamycin is used to treat patients harbouring iMLSB Staphylococcus, selection for constitutive erm mutants occur leading to therapeutic failure [7] . The objective of the present study was to investigate the prevalence of inducible clindamycin resistance among Staphylococcus aureus isolated from our teaching hospital and to detect their distribution among Methicillinresistant Staphylococcus aureus (MRSA). 
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